. Author manuscript; available in PMC: 2023 Nov 30.

Published in final edited form as: ACS Appl Mater Interfaces. 2022 May 31;14(23):27515–27522. doi: 10.1021/acsami.2c07012

Table 1.

Description of the antibiotic screened in this study using S. aureus (CD-35) and E. coli (CD-2). The antibiotics marked with an asterisk were used in the training set and their mechanism of action was known.

#	Antibiotics Name	Mode of Action	Antibiotic Class	Test Strain

1)	Ciprofloxacin	Interfere with bacterial DNA replication and transcription.⁴⁰	Quinolones	S. aureus (CD-35)
2)	Levofloxacin*
3)	Moxifloxacin*

4)	Ceftazidime*	Inhibit bacterial cell wall biosynthesis by binding with penicillin-binding proteins.⁴¹	Cephalosporins
5)	Cefotaxime		Cephalosporins

6)	Chloramphenicol*	Inhibits synthesis of proteins preventing growth.⁴²	Chloramphenicol

7)	Vancomycin	Disrupt cross-linking of bacterial peptidoglycan cell wall biosynthesis.⁴³	Glycopeptides

1)	Ciprofloxacin	Interfere with bacteria DNA replication and transcription.	Quinolones	E.coli (CD-2)
2)	Levofloxacin
3)	Moxifloxacin

4)	Ceftazidime	Inhibit bacterial cell wall biosynthesis by binding with penicillin-binding proteins.	Cephalosporins
5)	Cefotaxime		Cephalosporins

6)	Oxacillin	Inhibit bacterial cell wall biosynthesis.⁴⁴	β-lactams
7)	Amoxicillin	Inhibit bacterial cell wall biosynthesis.⁴⁴	β-lactams